Correlation Between Niraj Ispat and Mangalam Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Niraj Ispat and Mangalam Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Niraj Ispat and Mangalam Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Niraj Ispat Industries and Mangalam Drugs And, you can compare the effects of market volatilities on Niraj Ispat and Mangalam Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Niraj Ispat with a short position of Mangalam Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Niraj Ispat and Mangalam Drugs.

Diversification Opportunities for Niraj Ispat and Mangalam Drugs

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Niraj and Mangalam is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Niraj Ispat Industries and Mangalam Drugs And in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mangalam Drugs And and Niraj Ispat is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Niraj Ispat Industries are associated (or correlated) with Mangalam Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mangalam Drugs And has no effect on the direction of Niraj Ispat i.e., Niraj Ispat and Mangalam Drugs go up and down completely randomly.

Pair Corralation between Niraj Ispat and Mangalam Drugs

Assuming the 90 days trading horizon Niraj Ispat Industries is expected to generate 1.19 times more return on investment than Mangalam Drugs. However, Niraj Ispat is 1.19 times more volatile than Mangalam Drugs And. It trades about 0.06 of its potential returns per unit of risk. Mangalam Drugs And is currently generating about -0.01 per unit of risk. If you would invest  11,200  in Niraj Ispat Industries on August 30, 2024 and sell it today you would earn a total of  10,242  from holding Niraj Ispat Industries or generate 91.45% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy99.18%
ValuesDaily Returns

Niraj Ispat Industries  vs.  Mangalam Drugs And

 Performance 
       Timeline  
Niraj Ispat Industries 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Niraj Ispat Industries are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Niraj Ispat may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Mangalam Drugs And 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mangalam Drugs And has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's essential indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Niraj Ispat and Mangalam Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Niraj Ispat and Mangalam Drugs

The main advantage of trading using opposite Niraj Ispat and Mangalam Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Niraj Ispat position performs unexpectedly, Mangalam Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mangalam Drugs will offset losses from the drop in Mangalam Drugs' long position.
The idea behind Niraj Ispat Industries and Mangalam Drugs And pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance